| | | Novo Nordisk bids $3.1 billion for Belgian biotech group Ablynx | | | BRUSSELS (Reuters) - Denmark's Novo Nordisk , the world's biggest maker of insulin, has made a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx as it seeks to diversify and strengthen its business for treating rare blood disorders. |
| |
| Siemens to list Healthineers unit in March: sources | | | MUNICH (Reuters) - Siemens is planning to list its 40 billion euro ($47.94 billion) healthcare unit Healthineers in March, two people close to the matter said, as the group hopes to execute the deal while market conditions are favourable. |
| |
| Celgene to buy Impact Biomedicines for up to $7 billion | | | NEW YORK (Reuters) - U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance. |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today | |
| | | | | Get a jump on the day with our early morning summary of key news developments for the US markets, as well as global market news. Register Today | |
| | | » » MORE NEWSLETTERS | |
|
